Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

  1. Porta, C.
  2. Levy, A.
  3. Hawkins, R.
  4. Castellano, D.
  5. Bellmunt, J.
  6. Nathan, P.
  7. Mcdermott, R.
  8. Wagstaff, J.
  9. Donnellan, P.
  10. Mccaffrey, J.
  11. Vekeman, F.
  12. Neary, M.P.
  13. Diaz, J.
  14. Mehmud, F.
  15. Duh, M.S.
Revista:
Cancer Medicine

ISSN: 2045-7634

Ano de publicación: 2014

Volume: 3

Número: 6

Páxinas: 1517-1526

Tipo: Artigo

DOI: 10.1002/CAM4.302 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus